Key result
Diagnosis of myocardial infarction based only on increased troponins was associated with lower 28-day case-fatality but higher two-year cardiovascular mortality.
Why the study?
Does the 2000 ESC/ACC myocardial infarction definition (adding troponin) alter reported incidence, mortality, and prognosis compared to the 1994 WHO definition in patients aged 35-74?
Cohort (n=4,170)
Does the 2000 ESC/ACC myocardial infarction definition (adding troponin) alter reported incidence, mortality, and prognosis compared to the 1994 WHO definition in patients aged 35-74?
Answers are grounded in this paper and cite their sources.
Adopting the troponin-based 2000 ESC/ACC MI definition increases reported incidence and lowers short-term case-fatality, but identifies a troponin-only cohort with higher long-term mortality that may be undertreated.
AIMS: To analyse differences in myocardial infarction incidence, mortality and hospitalization rates, 28-day case-fatality and two-year prognosis using two myocardial infarction case definitions: the classical World Health Organization definition (1994) and the European Society of Cardiology/American College of Cardiology definition (2000), which added cardiac troponin as a diagnostic biomarker. DESIGN: Population-based cohort of 4170 consecutive myocardial infarction patients aged 35-74 years from Girona (Spain) recruited between 2002 and 2009. METHODS: Incidence, mortality rates standardized to the European population and 28-day case-fatality were calculated. To estimate the association between case definition and prognosis, Cox models were fitted. RESULTS: Use of the 2000 European Society of Cardiology/American College of Cardiology definition significantly increased myocardial infarction incidence per 100,000 population (238.3 vs. 274.5 in men and 54.1 vs. 69.7 in women). Applying this definition decreased the 28-day case-fatality rate from 26.9% to 23.4% in men, and from 31.0% to 24.1% in women. In the acute phase, patients diagnosed only by increased troponins were significantly less treated with thrombolysis (34.4% vs. 2.0%), angiotensin-converting enzyme inhibitors (71.7% vs. 65.0%) and percutaneous coronary intervention (41.1% vs. 31.7%). Case-fatality at 28 days was significantly better in cases diagnosed only by troponin increase (0.2 % vs. 9.7%), but two-year cardiovascular mortality was higher (7.5% vs. 3.7%). CONCLUSIONS: Inclusion of cardiac troponins in myocardial infarction diagnosis increased annual incidence and decreased case-fatality. Diagnosis based only on increased troponins was associated with worse outcome. This group of patients at high risk of death should receive aggressive secondary prevention therapy.
No takes yet. Share an insight, caveat, or question.
Agüero et al. (2014) conducted a cohort in myocardial infarction (n=4,170). Diagnosis based only on increased troponins vs. Diagnosis by classical criteria was evaluated on Two-year cardiovascular mortality. Diagnosis of myocardial infarction based only on increased troponins was associated with lower 28-day case-fatality but higher two-year cardiovascular mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: